bridge to surgery

bridge to surgery

The use of a colonic stent to ensure faecal flow in a patient who is currently regarded as too unstable or weak for surgery, but for whom definitive surgery—e.g., resection of an obstructing cancer—is planned.
References in periodicals archive ?
R]] is used to treat patients with HCC who can have placement of appropriately positioned hepatic arterial catheters, and can be used as a bridge to surgery or transplantation in these patients.
In the US, TheraSphere is used to treat patients with unresectable hepatocellular carcinoma (HCC), the most common form of primary liver cancer, and can be used as a bridge to surgery or transplantation in these patients.
Endoscopically placed self-expanding metal stents are now used in the management of patients with malignant obstruction of the left colon, both as a bridge to surgery in patients with curable lesions and in the palliative setting in patients with incurable metastatic disease.
The indication for stenting was palliation of colorectal cancer in the majority of patients in the multicenter series; in 29 others, stenting was intended as a bridge to surgery.
In the US, TheraSphere([R]) is used to treat patients with hepatocellular carcinoma (HCC) who can have appropriately positioned hepatic arterial catheters, and can be used as a bridge to surgery or transplantation in these patients.
TheraSphere is used to treat patients with unresectable hepatocellular carcinoma (HCC) and can be used as a bridge to surgery or transplantation in these patients.
In a recent multi-center, international registry study of 80 patients, the Evolution Colonic Controlled-Release Stent was evaluated for use in palliation of symptoms and as a bridge to surgery.
The second publication, appearing in the December 2011 issue of The American Journal of Gastroenterology, reports on 182 patients from the WallFlex Colonic Stent registries who received a WallFlex Colonic Stent as a bridge to surgery.
TheraSphere, 100% reimbursed by Medicare and many commercial health insurers, is used to treat patients with unresectable hepatocellular carcinoma (HCC) and can be used as a bridge to surgery or transplantation in these patients.